Author
Thiago C. Genaro‐Mattos
Also Known As
Genaro-Mattos, Thiago C., T. C. Genaro-Mattos, Thiago C Genaro-Mattos, Thiago C. Genaro-Mattos, Thiago C. Genaro-Mattos (732604), Thiago C. Genaro‐Mattos, Thiago Cardoso Genaro-Mattos, Thiago Genaro-Mattos
48
Publications
1.5K
Citations
21
H-Index
48
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 11 | 11 | 598 |
2 | Biochemistry | 9 | 9 | 573 |
3 | Natural Sciences | 5 | 5 | 96 |
4 | Social Sciences | 1 | 1 | 12 |
5 | Biostatistics | 1 | 1 | 14 |
Thiago C. Genaro‐Mattos
×
26
Publications
1.1K
Citations
18
H-Index
| Year | Citations | |
|---|---|---|
2024 | 252 | |
2015 | 197 | |
2019 | 104 | |
2019 | 52 | |
2013 | 38 | |
Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis Thiago C. Genaro‐Mattos, Keri A. Tallman, Luke B. Allen, Toxicology and Applied Pharmacology Cholesterol BiosynthesisInhibitory ActivityOxysterolBiochemistryDichlorophenyl Piperazines | 2018 | 34 |
2019 | 31 | |
2021 | 31 | |
2021 | 30 | |
2018 | 28 |
Page 1
Page 1